Berti Roesener - Elevate Uranium Consulting Namibia
| ELVUF Stock | USD 0.18 0.02 10.00% |
Insider
Berti Roesener is Consulting Namibia of Elevate Uranium
| Phone | 61 8 6555 1816 |
| Web | https://www.elevateuranium.com.au |
Elevate Uranium Management Efficiency
The company has return on total asset (ROA) of (0.2417) % which means that it has lost $0.2417 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.409) %, meaning that it generated substantial loss on money invested by shareholders. Elevate Uranium's management efficiency ratios could be used to measure how well Elevate Uranium manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Steven BSc | Ur Energy | 60 | |
| Andrew Carmichael | Isoenergy | N/A | |
| Tony George | NexGen Energy | N/A | |
| CGMA CPA | Ur Energy | 64 | |
| Erik Essiger | Uranium Energy Corp | 58 | |
| BA ACA | NexGen Energy | 52 | |
| Kevin Harrill | Centrus Energy | 47 | |
| Anthony George | NexGen Energy | N/A | |
| Elizabeth Williamson | Isoenergy | N/A | |
| Jesse BSc | Paladin Energy | N/A | |
| BBA CA | Purepoint Uranium Group | 64 | |
| W Jagodinski | Centrus Energy | 61 | |
| Don Hatcher | Centrus Energy | N/A | |
| Gloria Moya | Uranium Energy Corp | 43 | |
| W Boberg | Ur Energy | 79 | |
| Jeremy Ryan | Paladin Energy | N/A | |
| Bradley Wall | NexGen Energy | 54 | |
| Karen Oswald | Paladin Energy | N/A | |
| Alexander Rybak | Paladin Energy | N/A | |
| Gillian McCombie | NexGen Energy | N/A | |
| Harp Gosal | NexGen Energy | N/A | |
Management Performance
| Return On Equity | -0.41 | |||
| Return On Asset | -0.24 |
Elevate Uranium Leadership Team
Elected by the shareholders, the Elevate Uranium's board of directors comprises two types of representatives: Elevate Uranium inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Elevate. The board's role is to monitor Elevate Uranium's management team and ensure that shareholders' interests are well served. Elevate Uranium's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Elevate Uranium's outside directors are responsible for providing unbiased perspectives on the board's policies.
| BBus FCIS, CFO Sec | ||
| BSc PGeo, Consulting Geologist | ||
| Berti Roesener, Consulting Namibia | ||
| Fausimm BSc, CEO MD | ||
| Jessica Bezuidenhout, Gen Namibia |
Elevate Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right otc stock is not an easy task. Is Elevate Uranium a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.41 | |||
| Return On Asset | -0.24 | |||
| Current Valuation | 59.41 M | |||
| Shares Outstanding | 275.5 M | |||
| Shares Owned By Insiders | 16.66 % | |||
| Shares Owned By Institutions | 10.13 % | |||
| Price To Book | 5.94 X | |||
| Price To Sales | 1,137 X | |||
| Revenue | 116.86 K | |||
| Gross Profit | 116.86 K |
Currently Active Assets on Macroaxis
Other Information on Investing in Elevate OTC Stock
Elevate Uranium financial ratios help investors to determine whether Elevate OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Elevate with respect to the benefits of owning Elevate Uranium security.